Clinical Trial Update: 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update comparing 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT imaging in the same group of prostate cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-P16-093 (P16-093 Ga-68 radiopharmaceutical)
• 68Ga-PSMA-617

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: UNKNOWN